HETEROGENEOUS EXPRESSION OF CARCINOEMBRYONIC ANTIGEN IN THE NORMAL COLON AND UPREGULATION IN ACTIVE ULCERATIVE COLITIS
β Scribed by SMITHSON, JOHN E.; WARREN, BRYAN F.; YOUNG, SUSAN; PIGOTT, ROD; JEWELL, DEREK P.
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 638 KB
- Volume
- 180
- Category
- Article
- ISSN
- 0022-3417
No coin nor oath required. For personal study only.
β¦ Synopsis
Using a technique of tolerization, a murine monoclonal antibody (MAb 2E8) has been raised which displays regional differences in reactivity in the epithelium of the normal human colon and increased reactivity in active ulcerative colitis. MAb 2ES (IgC,) was highly colon-specific and gave higher immunoperoxidase staining scores in the proximal colonic mucosa compared with paired rectal sections (P<O.O2). Expression of the antigen reactive with MAb 2ES was enhanced in active ulcerative colitis compared with quiescent ulcerative colitis ( P < O 4 5 ) and normal controls (P<O*OOl). Western blotting and indirect immunofluorescent screening on transfected cell lines established that MAb 2ES was reactive with carcinoembryonic antigen (CEA). This is the first demonstration of regional differences in the expression of CEA in the normal colon and indicates upregulation of this molecule in active ulcerative colitis.
π SIMILAR VOLUMES
## Background: The aim of this study was to assess the activity of eosinophils, neutrophils, and CD4ΓΎ as well as CD8ΓΎ T-cells in 11 patients with active collagenous colitis (CC) before and after 8 weeks of budesonide treatment (9 mg once daily) compared to 10 healthy individuals. Methods: Clinica
Background: Interleukin (IL)-17F, produced in IL-23R-expressing Th17 cells, is a novel member of the IL-17 cytokine family. Given the association of IL23R with inflammatory bowel disease (IBD), we characterized the role of IL-17F in IBD including its intestinal gene expression and the effect of the